Global Toxoplasmosis Testing Market Growth (Status and Outlook) 2026-2032

Product Code: 2019711

Industry: Medical Care

Published: Jul 05,2026

Pages: 135

Delivery Time: 2-3 business days

Global Toxoplasmosis Testing Market Growth (Status and Outlook) 2026-2032

Product Code: 2019711

Industry: Medical Care

Published: Jul 05,2026

Pages: 135

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Toxoplasmosis Testing market size is predicted to grow from US$ 533 million in 2025 to US$ 839 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

The gross profit margin of major companies in the industry is between 35%–55%.

Toxoplasmosis Testing refers to diagnostic products and services used to detect Toxoplasma gondii infection through antibody, antigen, molecular, or rapid testing methods. Common formats include ELISA, chemiluminescence assays, PCR-based tests, immunochromatographic tests, and confirmatory laboratory testing. It is mainly used in prenatal screening, immunocompromised patient monitoring, transplant evaluation, ophthalmic infection diagnosis, veterinary testing, and public health surveillance. The product boundary excludes toxoplasmosis drugs, general parasitic disease panels without specific toxoplasmosis markers, imaging services, and non-diagnostic research reagents.

The industry chain begins with antigens, antibodies, primers, probes, enzymes, membranes, buffers, plastic consumables, diagnostic instruments, and quality control materials. Midstream participants develop assay kits, rapid test formats, laboratory testing workflows, packaging, validation, regulatory documentation, and distribution systems. Downstream demand comes from hospitals, diagnostic laboratories, prenatal screening centers, transplant centers, public health agencies, veterinary clinics, and research institutions. Growth is driven by congenital infection prevention, immune-compromised patient testing, expanded molecular diagnostics, and broader access to infectious disease screening.

Toxoplasmosis Testing is widely used in hospital clinical labs, maternal screening and animal quarantine for rapid pathogen identification. It features high detection accuracy, simple operation and fast output of results. Growing prenatal care and livestock epidemic prevention needs fuel market expansion. Future development focuses on portable rapid test kits and high-throughput automated detection platforms.

LPI (LP Information)' newest research report, the “Toxoplasmosis Testing Industry Forecast” looks at past sales and reviews total world Toxoplasmosis Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Toxoplasmosis Testing sales for 2026 through 2032. With Toxoplasmosis Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Toxoplasmosis Testing industry.

This Insight Report provides a comprehensive analysis of the global Toxoplasmosis Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Toxoplasmosis Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Toxoplasmosis Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Toxoplasmosis Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Toxoplasmosis Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Toxoplasmosis Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Serological Antibody Testing
    Molecular Nucleic Acid Testing
    Microscopic Pathogen Testing

Segmentation by Sample Type:
    Blood Sample Testing
    Amniotic Fluid Testing
    Cerebrospinal Fluid and Tissue Testing

Segmentation by Detection Time:
    Rapid Type（≤30 min）
    Standard Type（＞30 min-4 h）
    Batch Laboratory Type（＞4 h）

Segmentation by Application:
    Hospitals
    Diagnostic Laboratories
    Public Health and Reference Laboratories
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Abbott Laboratories
    Roche Diagnostics
    Siemens Healthineers
    bioMérieux
    DiaSorin S.p.A.
    Bio-Rad Laboratories
    Danaher (Beckman Coulter / Cepheid)
    Thermo Fisher Scientific
    Euroimmun (Revvity / PerkinElmer)
    Hologic
    Autobio Diagnostics
    YHLO Biotech (Shenzhen YHLO)
    Maccura Biotechnology
    Wondfo Biotech
    Sansure Biotech
    Shanghai Kehua Bio-Engineering
    Getein Biotech
    Zhejiang Orient Gene Biotech

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Toxoplasmosis Testing Market Size (2021-2032)
        2.1.2 Toxoplasmosis Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
        2.1.3 World Current & Future Analysis for Toxoplasmosis Testing by Country/Region (2021, 2025 & 2032)
    2.2 Toxoplasmosis Testing Segment by Type
        2.2.1 Serological Antibody Testing
        2.2.2 Molecular Nucleic Acid Testing
        2.2.3 Microscopic Pathogen Testing
        2.2.4 Toxoplasmosis Testing Market Size by Type
            2.2.4.1 Toxoplasmosis Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
            2.2.4.2 Global Toxoplasmosis Testing Market Size Market Share by Type (2021-2026)
    2.3 Toxoplasmosis Testing Segment by Sample Type
        2.3.1 Blood Sample Testing
        2.3.2 Amniotic Fluid Testing
        2.3.3 Cerebrospinal Fluid and Tissue Testing
        2.3.4 Toxoplasmosis Testing Market Size by Sample Type
            2.3.4.1 Toxoplasmosis Testing Market Size CAGR by Sample Type (2021 VS 2025 VS 2032)
            2.3.4.2 Global Toxoplasmosis Testing Market Size Market Share by Sample Type (2021-2026)
    2.4 Toxoplasmosis Testing Segment by Detection Time
        2.4.1 Rapid Type（≤30 min）
        2.4.2 Standard Type（＞30 min-4 h）
        2.4.3 Batch Laboratory Type（＞4 h）
        2.4.4 Toxoplasmosis Testing Market Size by Detection Time
            2.4.4.1 Toxoplasmosis Testing Market Size CAGR by Detection Time (2021 VS 2025 VS 2032)
            2.4.4.2 Global Toxoplasmosis Testing Market Size Market Share by Detection Time (2021-2026)
    2.5 Toxoplasmosis Testing Segment by Application
        2.5.1 Hospitals
        2.5.2 Diagnostic Laboratories
        2.5.3 Public Health and Reference Laboratories
        2.5.4 Other
        2.5.5 Toxoplasmosis Testing Market Size by Application
            2.5.5.1 Toxoplasmosis Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
            2.5.5.2 Global Toxoplasmosis Testing Market Size Market Share by Application (2021-2026)

3 Toxoplasmosis Testing Market Size by Player
    3.1 Toxoplasmosis Testing Market Size Market Share by Player
        3.1.1 Global Toxoplasmosis Testing Revenue by Player (2021-2026)
        3.1.2 Global Toxoplasmosis Testing Revenue Market Share by Player (2021-2026)
    3.2 Global Toxoplasmosis Testing Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Toxoplasmosis Testing by Region
    4.1 Toxoplasmosis Testing Market Size by Region (2021-2026)
    4.2 Global Toxoplasmosis Testing Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Toxoplasmosis Testing Market Size Growth (2021-2026)
    4.4 APAC Toxoplasmosis Testing Market Size Growth (2021-2026)
    4.5 Europe Toxoplasmosis Testing Market Size Growth (2021-2026)
    4.6 Middle East & Africa Toxoplasmosis Testing Market Size Growth (2021-2026)

5 Americas
    5.1 Americas Toxoplasmosis Testing Market Size by Country (2021-2026)
    5.2 Americas Toxoplasmosis Testing Market Size by Type (2021-2026)
    5.3 Americas Toxoplasmosis Testing Market Size by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Toxoplasmosis Testing Market Size by Region (2021-2026)
    6.2 APAC Toxoplasmosis Testing Market Size by Type (2021-2026)
    6.3 APAC Toxoplasmosis Testing Market Size by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Toxoplasmosis Testing Market Size by Country (2021-2026)
    7.2 Europe Toxoplasmosis Testing Market Size by Type (2021-2026)
    7.3 Europe Toxoplasmosis Testing Market Size by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Toxoplasmosis Testing by Region (2021-2026)
    8.2 Middle East & Africa Toxoplasmosis Testing Market Size by Type (2021-2026)
    8.3 Middle East & Africa Toxoplasmosis Testing Market Size by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Toxoplasmosis Testing Market Forecast
    10.1 Global Toxoplasmosis Testing Forecast by Region (2027-2032)
        10.1.1 Global Toxoplasmosis Testing Forecast by Region (2027-2032)
        10.1.2 Americas Toxoplasmosis Testing Forecast
        10.1.3 APAC Toxoplasmosis Testing Forecast
        10.1.4 Europe Toxoplasmosis Testing Forecast
        10.1.5 Middle East & Africa Toxoplasmosis Testing Forecast
    10.2 Americas Toxoplasmosis Testing Forecast by Country (2027-2032)
        10.2.1 United States Market Toxoplasmosis Testing Forecast
        10.2.2 Canada Market Toxoplasmosis Testing Forecast
        10.2.3 Mexico Market Toxoplasmosis Testing Forecast
        10.2.4 Brazil Market Toxoplasmosis Testing Forecast
    10.3 APAC Toxoplasmosis Testing Forecast by Region (2027-2032)
        10.3.1 China Toxoplasmosis Testing Market Forecast
        10.3.2 Japan Market Toxoplasmosis Testing Forecast
        10.3.3 Korea Market Toxoplasmosis Testing Forecast
        10.3.4 Southeast Asia Market Toxoplasmosis Testing Forecast
        10.3.5 India Market Toxoplasmosis Testing Forecast
        10.3.6 Australia Market Toxoplasmosis Testing Forecast
    10.4 Europe Toxoplasmosis Testing Forecast by Country (2027-2032)
        10.4.1 Germany Market Toxoplasmosis Testing Forecast
        10.4.2 France Market Toxoplasmosis Testing Forecast
        10.4.3 UK Market Toxoplasmosis Testing Forecast
        10.4.4 Italy Market Toxoplasmosis Testing Forecast
        10.4.5 Russia Market Toxoplasmosis Testing Forecast
    10.5 Middle East & Africa Toxoplasmosis Testing Forecast by Region (2027-2032)
        10.5.1 Egypt Market Toxoplasmosis Testing Forecast
        10.5.2 South Africa Market Toxoplasmosis Testing Forecast
        10.5.3 Israel Market Toxoplasmosis Testing Forecast
        10.5.4 Turkey Market Toxoplasmosis Testing Forecast
    10.6 Global Toxoplasmosis Testing Forecast by Type (2027-2032)
    10.7 Global Toxoplasmosis Testing Forecast by Application (2027-2032)
        10.7.1 GCC Countries Market Toxoplasmosis Testing Forecast

11 Key Players Analysis
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Information
        11.1.2 Abbott Laboratories Toxoplasmosis Testing Product Offered
        11.1.3 Abbott Laboratories Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.1.4 Abbott Laboratories Main Business Overview
        11.1.5 Abbott Laboratories Latest Developments
    11.2 Roche Diagnostics
        11.2.1 Roche Diagnostics Company Information
        11.2.2 Roche Diagnostics Toxoplasmosis Testing Product Offered
        11.2.3 Roche Diagnostics Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.2.4 Roche Diagnostics Main Business Overview
        11.2.5 Roche Diagnostics Latest Developments
    11.3 Siemens Healthineers
        11.3.1 Siemens Healthineers Company Information
        11.3.2 Siemens Healthineers Toxoplasmosis Testing Product Offered
        11.3.3 Siemens Healthineers Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.3.4 Siemens Healthineers Main Business Overview
        11.3.5 Siemens Healthineers Latest Developments
    11.4 bioMérieux
        11.4.1 bioMérieux Company Information
        11.4.2 bioMérieux Toxoplasmosis Testing Product Offered
        11.4.3 bioMérieux Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.4.4 bioMérieux Main Business Overview
        11.4.5 bioMérieux Latest Developments
    11.5 DiaSorin S.p.A.
        11.5.1 DiaSorin S.p.A. Company Information
        11.5.2 DiaSorin S.p.A. Toxoplasmosis Testing Product Offered
        11.5.3 DiaSorin S.p.A. Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.5.4 DiaSorin S.p.A. Main Business Overview
        11.5.5 DiaSorin S.p.A. Latest Developments
    11.6 Bio-Rad Laboratories
        11.6.1 Bio-Rad Laboratories Company Information
        11.6.2 Bio-Rad Laboratories Toxoplasmosis Testing Product Offered
        11.6.3 Bio-Rad Laboratories Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.6.4 Bio-Rad Laboratories Main Business Overview
        11.6.5 Bio-Rad Laboratories Latest Developments
    11.7 Danaher (Beckman Coulter / Cepheid)
        11.7.1 Danaher (Beckman Coulter / Cepheid) Company Information
        11.7.2 Danaher (Beckman Coulter / Cepheid) Toxoplasmosis Testing Product Offered
        11.7.3 Danaher (Beckman Coulter / Cepheid) Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.7.4 Danaher (Beckman Coulter / Cepheid) Main Business Overview
        11.7.5 Danaher (Beckman Coulter / Cepheid) Latest Developments
    11.8 Thermo Fisher Scientific
        11.8.1 Thermo Fisher Scientific Company Information
        11.8.2 Thermo Fisher Scientific Toxoplasmosis Testing Product Offered
        11.8.3 Thermo Fisher Scientific Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.8.4 Thermo Fisher Scientific Main Business Overview
        11.8.5 Thermo Fisher Scientific Latest Developments
    11.9 Euroimmun (Revvity / PerkinElmer)
        11.9.1 Euroimmun (Revvity / PerkinElmer) Company Information
        11.9.2 Euroimmun (Revvity / PerkinElmer) Toxoplasmosis Testing Product Offered
        11.9.3 Euroimmun (Revvity / PerkinElmer) Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.9.4 Euroimmun (Revvity / PerkinElmer) Main Business Overview
        11.9.5 Euroimmun (Revvity / PerkinElmer) Latest Developments
    11.10 Hologic
        11.10.1 Hologic Company Information
        11.10.2 Hologic Toxoplasmosis Testing Product Offered
        11.10.3 Hologic Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.10.4 Hologic Main Business Overview
        11.10.5 Hologic Latest Developments
    11.11 Autobio Diagnostics
        11.11.1 Autobio Diagnostics Company Information
        11.11.2 Autobio Diagnostics Toxoplasmosis Testing Product Offered
        11.11.3 Autobio Diagnostics Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.11.4 Autobio Diagnostics Main Business Overview
        11.11.5 Autobio Diagnostics Latest Developments
    11.12 YHLO Biotech (Shenzhen YHLO)
        11.12.1 YHLO Biotech (Shenzhen YHLO) Company Information
        11.12.2 YHLO Biotech (Shenzhen YHLO) Toxoplasmosis Testing Product Offered
        11.12.3 YHLO Biotech (Shenzhen YHLO) Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.12.4 YHLO Biotech (Shenzhen YHLO) Main Business Overview
        11.12.5 YHLO Biotech (Shenzhen YHLO) Latest Developments
    11.13 Maccura Biotechnology
        11.13.1 Maccura Biotechnology Company Information
        11.13.2 Maccura Biotechnology Toxoplasmosis Testing Product Offered
        11.13.3 Maccura Biotechnology Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.13.4 Maccura Biotechnology Main Business Overview
        11.13.5 Maccura Biotechnology Latest Developments
    11.14 Wondfo Biotech
        11.14.1 Wondfo Biotech Company Information
        11.14.2 Wondfo Biotech Toxoplasmosis Testing Product Offered
        11.14.3 Wondfo Biotech Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.14.4 Wondfo Biotech Main Business Overview
        11.14.5 Wondfo Biotech Latest Developments
    11.15 Sansure Biotech
        11.15.1 Sansure Biotech Company Information
        11.15.2 Sansure Biotech Toxoplasmosis Testing Product Offered
        11.15.3 Sansure Biotech Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.15.4 Sansure Biotech Main Business Overview
        11.15.5 Sansure Biotech Latest Developments
    11.16 Shanghai Kehua Bio-Engineering
        11.16.1 Shanghai Kehua Bio-Engineering Company Information
        11.16.2 Shanghai Kehua Bio-Engineering Toxoplasmosis Testing Product Offered
        11.16.3 Shanghai Kehua Bio-Engineering Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.16.4 Shanghai Kehua Bio-Engineering Main Business Overview
        11.16.5 Shanghai Kehua Bio-Engineering Latest Developments
    11.17 Getein Biotech
        11.17.1 Getein Biotech Company Information
        11.17.2 Getein Biotech Toxoplasmosis Testing Product Offered
        11.17.3 Getein Biotech Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.17.4 Getein Biotech Main Business Overview
        11.17.5 Getein Biotech Latest Developments
    11.18 Zhejiang Orient Gene Biotech
        11.18.1 Zhejiang Orient Gene Biotech Company Information
        11.18.2 Zhejiang Orient Gene Biotech Toxoplasmosis Testing Product Offered
        11.18.3 Zhejiang Orient Gene Biotech Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2021-2026)
        11.18.4 Zhejiang Orient Gene Biotech Main Business Overview
        11.18.5 Zhejiang Orient Gene Biotech Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Toxoplasmosis Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
 Table 2. Toxoplasmosis Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Serological Antibody Testing
 Table 4. Major Players of Molecular Nucleic Acid Testing
 Table 5. Major Players of Microscopic Pathogen Testing
 Table 6. Toxoplasmosis Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
 Table 7. Global Toxoplasmosis Testing Market Size by Type (2021-2026) & ($ millions)
 Table 8. Global Toxoplasmosis Testing Market Size Market Share by Type (2021-2026)
 Table 9. Major Players of Blood Sample Testing
 Table 10. Major Players of Amniotic Fluid Testing
 Table 11. Major Players of Cerebrospinal Fluid and Tissue Testing
 Table 12. Toxoplasmosis Testing Market Size CAGR by Sample Type (2021 VS 2025 VS 2032) & ($ millions)
 Table 13. Global Toxoplasmosis Testing Market Size by Sample Type (2021-2026) & ($ millions)
 Table 14. Global Toxoplasmosis Testing Market Size Market Share by Sample Type (2021-2026)
 Table 15. Major Players of Rapid Type（≤30 min）
 Table 16. Major Players of Standard Type（＞30 min-4 h）
 Table 17. Major Players of Batch Laboratory Type（＞4 h）
 Table 18. Toxoplasmosis Testing Market Size CAGR by Detection Time (2021 VS 2025 VS 2032) & ($ millions)
 Table 19. Global Toxoplasmosis Testing Market Size by Detection Time (2021-2026) & ($ millions)
 Table 20. Global Toxoplasmosis Testing Market Size Market Share by Detection Time (2021-2026)
 Table 21. Toxoplasmosis Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
 Table 22. Global Toxoplasmosis Testing Market Size by Application (2021-2026) & ($ millions)
 Table 23. Global Toxoplasmosis Testing Market Size Market Share by Application (2021-2026)
 Table 24. Global Toxoplasmosis Testing Revenue by Player (2021-2026) & ($ millions)
 Table 25. Global Toxoplasmosis Testing Revenue Market Share by Player (2021-2026)
 Table 26. Toxoplasmosis Testing Key Players Head office and Products Offered
 Table 27. Toxoplasmosis Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 28. New Products and Potential Entrants
 Table 29. Mergers & Acquisitions, Expansion
 Table 30. Global Toxoplasmosis Testing Market Size by Region (2021-2026) & ($ millions)
 Table 31. Global Toxoplasmosis Testing Market Size Market Share by Region (2021-2026)
 Table 32. Global Toxoplasmosis Testing Revenue by Country/Region (2021-2026) & ($ millions)
 Table 33. Global Toxoplasmosis Testing Revenue Market Share by Country/Region (2021-2026)
 Table 34. Americas Toxoplasmosis Testing Market Size by Country (2021-2026) & ($ millions)
 Table 35. Americas Toxoplasmosis Testing Market Size Market Share by Country (2021-2026)
 Table 36. Americas Toxoplasmosis Testing Market Size by Type (2021-2026) & ($ millions)
 Table 37. Americas Toxoplasmosis Testing Market Size Market Share by Type (2021-2026)
 Table 38. Americas Toxoplasmosis Testing Market Size by Application (2021-2026) & ($ millions)
 Table 39. Americas Toxoplasmosis Testing Market Size Market Share by Application (2021-2026)
 Table 40. APAC Toxoplasmosis Testing Market Size by Region (2021-2026) & ($ millions)
 Table 41. APAC Toxoplasmosis Testing Market Size Market Share by Region (2021-2026)
 Table 42. APAC Toxoplasmosis Testing Market Size by Type (2021-2026) & ($ millions)
 Table 43. APAC Toxoplasmosis Testing Market Size by Application (2021-2026) & ($ millions)
 Table 44. Europe Toxoplasmosis Testing Market Size by Country (2021-2026) & ($ millions)
 Table 45. Europe Toxoplasmosis Testing Market Size Market Share by Country (2021-2026)
 Table 46. Europe Toxoplasmosis Testing Market Size by Type (2021-2026) & ($ millions)
 Table 47. Europe Toxoplasmosis Testing Market Size by Application (2021-2026) & ($ millions)
 Table 48. Middle East & Africa Toxoplasmosis Testing Market Size by Region (2021-2026) & ($ millions)
 Table 49. Middle East & Africa Toxoplasmosis Testing Market Size by Type (2021-2026) & ($ millions)
 Table 50. Middle East & Africa Toxoplasmosis Testing Market Size by Application (2021-2026) & ($ millions)
 Table 51. Key Market Drivers & Growth Opportunities of Toxoplasmosis Testing
 Table 52. Key Market Challenges & Risks of Toxoplasmosis Testing
 Table 53. Key Industry Trends of Toxoplasmosis Testing
 Table 54. Global Toxoplasmosis Testing Market Size Forecast by Region (2027-2032) & ($ millions)
 Table 55. Global Toxoplasmosis Testing Market Size Market Share Forecast by Region (2027-2032)
 Table 56. Global Toxoplasmosis Testing Market Size Forecast by Type (2027-2032) & ($ millions)
 Table 57. Global Toxoplasmosis Testing Market Size Forecast by Application (2027-2032) & ($ millions)
 Table 58. Abbott Laboratories Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 59. Abbott Laboratories Toxoplasmosis Testing Product Offered
 Table 60. Abbott Laboratories Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 61. Abbott Laboratories Main Business
 Table 62. Abbott Laboratories Latest Developments
 Table 63. Roche Diagnostics Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 64. Roche Diagnostics Toxoplasmosis Testing Product Offered
 Table 65. Roche Diagnostics Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 66. Roche Diagnostics Main Business
 Table 67. Roche Diagnostics Latest Developments
 Table 68. Siemens Healthineers Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 69. Siemens Healthineers Toxoplasmosis Testing Product Offered
 Table 70. Siemens Healthineers Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 71. Siemens Healthineers Main Business
 Table 72. Siemens Healthineers Latest Developments
 Table 73. bioMérieux Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 74. bioMérieux Toxoplasmosis Testing Product Offered
 Table 75. bioMérieux Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 76. bioMérieux Main Business
 Table 77. bioMérieux Latest Developments
 Table 78. DiaSorin S.p.A. Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 79. DiaSorin S.p.A. Toxoplasmosis Testing Product Offered
 Table 80. DiaSorin S.p.A. Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 81. DiaSorin S.p.A. Main Business
 Table 82. DiaSorin S.p.A. Latest Developments
 Table 83. Bio-Rad Laboratories Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 84. Bio-Rad Laboratories Toxoplasmosis Testing Product Offered
 Table 85. Bio-Rad Laboratories Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 86. Bio-Rad Laboratories Main Business
 Table 87. Bio-Rad Laboratories Latest Developments
 Table 88. Danaher (Beckman Coulter / Cepheid) Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 89. Danaher (Beckman Coulter / Cepheid) Toxoplasmosis Testing Product Offered
 Table 90. Danaher (Beckman Coulter / Cepheid) Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 91. Danaher (Beckman Coulter / Cepheid) Main Business
 Table 92. Danaher (Beckman Coulter / Cepheid) Latest Developments
 Table 93. Thermo Fisher Scientific Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 94. Thermo Fisher Scientific Toxoplasmosis Testing Product Offered
 Table 95. Thermo Fisher Scientific Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 96. Thermo Fisher Scientific Main Business
 Table 97. Thermo Fisher Scientific Latest Developments
 Table 98. Euroimmun (Revvity / PerkinElmer) Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 99. Euroimmun (Revvity / PerkinElmer) Toxoplasmosis Testing Product Offered
 Table 100. Euroimmun (Revvity / PerkinElmer) Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 101. Euroimmun (Revvity / PerkinElmer) Main Business
 Table 102. Euroimmun (Revvity / PerkinElmer) Latest Developments
 Table 103. Hologic Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 104. Hologic Toxoplasmosis Testing Product Offered
 Table 105. Hologic Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 106. Hologic Main Business
 Table 107. Hologic Latest Developments
 Table 108. Autobio Diagnostics Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 109. Autobio Diagnostics Toxoplasmosis Testing Product Offered
 Table 110. Autobio Diagnostics Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 111. Autobio Diagnostics Main Business
 Table 112. Autobio Diagnostics Latest Developments
 Table 113. YHLO Biotech (Shenzhen YHLO) Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 114. YHLO Biotech (Shenzhen YHLO) Toxoplasmosis Testing Product Offered
 Table 115. YHLO Biotech (Shenzhen YHLO) Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 116. YHLO Biotech (Shenzhen YHLO) Main Business
 Table 117. YHLO Biotech (Shenzhen YHLO) Latest Developments
 Table 118. Maccura Biotechnology Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 119. Maccura Biotechnology Toxoplasmosis Testing Product Offered
 Table 120. Maccura Biotechnology Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 121. Maccura Biotechnology Main Business
 Table 122. Maccura Biotechnology Latest Developments
 Table 123. Wondfo Biotech Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 124. Wondfo Biotech Toxoplasmosis Testing Product Offered
 Table 125. Wondfo Biotech Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 126. Wondfo Biotech Main Business
 Table 127. Wondfo Biotech Latest Developments
 Table 128. Sansure Biotech Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 129. Sansure Biotech Toxoplasmosis Testing Product Offered
 Table 130. Sansure Biotech Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 131. Sansure Biotech Main Business
 Table 132. Sansure Biotech Latest Developments
 Table 133. Shanghai Kehua Bio-Engineering Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 134. Shanghai Kehua Bio-Engineering Toxoplasmosis Testing Product Offered
 Table 135. Shanghai Kehua Bio-Engineering Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 136. Shanghai Kehua Bio-Engineering Main Business
 Table 137. Shanghai Kehua Bio-Engineering Latest Developments
 Table 138. Getein Biotech Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 139. Getein Biotech Toxoplasmosis Testing Product Offered
 Table 140. Getein Biotech Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 141. Getein Biotech Main Business
 Table 142. Getein Biotech Latest Developments
 Table 143. Zhejiang Orient Gene Biotech Details, Company Type, Toxoplasmosis Testing Area Served and Its Competitors
 Table 144. Zhejiang Orient Gene Biotech Toxoplasmosis Testing Product Offered
 Table 145. Zhejiang Orient Gene Biotech Toxoplasmosis Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 146. Zhejiang Orient Gene Biotech Main Business
 Table 147. Zhejiang Orient Gene Biotech Latest Developments


List of Figures
 Figure 1. Toxoplasmosis Testing Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Toxoplasmosis Testing Market Size Growth Rate (2021-2032) ($ millions)
 Figure 6. Toxoplasmosis Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 7. Toxoplasmosis Testing Sales Market Share by Country/Region (2025)
 Figure 8. Toxoplasmosis Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 9. Global Toxoplasmosis Testing Market Size Market Share by Type in 2025
 Figure 10. Global Toxoplasmosis Testing Market Size Market Share by Sample Type in 2025
 Figure 11. Global Toxoplasmosis Testing Market Size Market Share by Detection Time in 2025
 Figure 12. Toxoplasmosis Testing in Hospitals
 Figure 13. Global Toxoplasmosis Testing Market: Hospitals (2021-2026) & ($ millions)
 Figure 14. Toxoplasmosis Testing in Diagnostic Laboratories
 Figure 15. Global Toxoplasmosis Testing Market: Diagnostic Laboratories (2021-2026) & ($ millions)
 Figure 16. Toxoplasmosis Testing in Public Health and Reference Laboratories
 Figure 17. Global Toxoplasmosis Testing Market: Public Health and Reference Laboratories (2021-2026) & ($ millions)
 Figure 18. Toxoplasmosis Testing in Other
 Figure 19. Global Toxoplasmosis Testing Market: Other (2021-2026) & ($ millions)
 Figure 20. Global Toxoplasmosis Testing Market Size Market Share by Application in 2025
 Figure 21. Global Toxoplasmosis Testing Revenue Market Share by Player in 2025
 Figure 22. Global Toxoplasmosis Testing Market Size Market Share by Region (2021-2026)
 Figure 23. Americas Toxoplasmosis Testing Market Size 2021-2026 ($ millions)
 Figure 24. APAC Toxoplasmosis Testing Market Size 2021-2026 ($ millions)
 Figure 25. Europe Toxoplasmosis Testing Market Size 2021-2026 ($ millions)
 Figure 26. Middle East & Africa Toxoplasmosis Testing Market Size 2021-2026 ($ millions)
 Figure 27. Americas Toxoplasmosis Testing Value Market Share by Country in 2025
 Figure 28. United States Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 29. Canada Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 30. Mexico Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 31. Brazil Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 32. APAC Toxoplasmosis Testing Market Size Market Share by Region in 2025
 Figure 33. APAC Toxoplasmosis Testing Market Size Market Share by Type (2021-2026)
 Figure 34. APAC Toxoplasmosis Testing Market Size Market Share by Application (2021-2026)
 Figure 35. China Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 36. Japan Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 37. South Korea Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 38. Southeast Asia Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 39. India Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 40. Australia Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 41. Europe Toxoplasmosis Testing Market Size Market Share by Country in 2025
 Figure 42. Europe Toxoplasmosis Testing Market Size Market Share by Type (2021-2026)
 Figure 43. Europe Toxoplasmosis Testing Market Size Market Share by Application (2021-2026)
 Figure 44. Germany Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 45. France Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 46. UK Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 47. Italy Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 48. Russia Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 49. Middle East & Africa Toxoplasmosis Testing Market Size Market Share by Region (2021-2026)
 Figure 50. Middle East & Africa Toxoplasmosis Testing Market Size Market Share by Type (2021-2026)
 Figure 51. Middle East & Africa Toxoplasmosis Testing Market Size Market Share by Application (2021-2026)
 Figure 52. Egypt Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 53. South Africa Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 54. Israel Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 55. Turkey Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 56. GCC Countries Toxoplasmosis Testing Market Size Growth 2021-2026 ($ millions)
 Figure 57. Americas Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 58. APAC Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 59. Europe Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 60. Middle East & Africa Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 61. United States Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 62. Canada Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 63. Mexico Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 64. Brazil Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 65. China Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 66. Japan Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 67. Korea Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 68. Southeast Asia Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 69. India Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 70. Australia Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 71. Germany Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 72. France Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 73. UK Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 74. Italy Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 75. Russia Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 76. Egypt Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 77. South Africa Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 78. Israel Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 79. Turkey Toxoplasmosis Testing Market Size 2027-2032 ($ millions)
 Figure 80. Global Toxoplasmosis Testing Market Size Market Share Forecast by Type (2027-2032)
 Figure 81. Global Toxoplasmosis Testing Market Size Market Share Forecast by Application (2027-2032)
 Figure 82. GCC Countries Toxoplasmosis Testing Market Size 2027-2032 ($ millions)

Companies Mentioned

Abbott Laboratories

Roche Diagnostics

Siemens Healthineers

bioMérieux

DiaSorin S.p.A.

Bio-Rad Laboratories

Danaher (Beckman Coulter / Cepheid)

Thermo Fisher Scientific

Euroimmun (Revvity / PerkinElmer)

Hologic

Autobio Diagnostics

YHLO Biotech (Shenzhen YHLO)

Maccura Biotechnology

Wondfo Biotech

Sansure Biotech

Shanghai Kehua Bio-Engineering

Getein Biotech

Zhejiang Orient Gene Biotech

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff